Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.6.1.1 (
adenylate cyclase
)
19,190
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The cervicovaginal epithelium of neonatal mice produces a material with specific antigenic properties (
CVA
) and this material is produced in increased amounts after estradiol treatment. Using a cytochemical method, estradiol treatment was shown to result in an increase of
adenylate cyclase
activity in the same epithelium. When d-propranolol is injected together with estradiol, the increase in
CVA
is inhibited, while the hormone-induced proliferation of epithelial cells is not influenced. When
adenylate cyclase
activity is studied under identical conditions, the estradiol-promoted increase in enzyme activity is largely counteracted by d-propranolol. These findings would suggest that Adenosine 3"5"-cyclic monophosphate (cAMP) has a role in some, but not all, estradiol-mediated effects in the neonatal cervicovaginal epithelium.
...
PMID:Effects of d-propranolol and estradiol on the cervicovaginal epithelium. 99 Dec 44